These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32079444)

  • 1. Super-resolution imaging and quantification of megakaryocytes and platelets.
    Khan AO; Pike JA
    Platelets; 2020 Jul; 31(5):559-569. PubMed ID: 32079444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seeing is believing: use of advanced imaging to study platelets and megakaryocytes.
    Thomas SG; Poulter NS
    Platelets; 2020 Jul; 31(5):549-550. PubMed ID: 32427510
    [No Abstract]   [Full Text] [Related]  

  • 3. The end is just the beginning: megakaryocyte apoptosis and platelet release.
    Li J; Kuter DJ
    Int J Hematol; 2001 Dec; 74(4):365-74. PubMed ID: 11794690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin of platelet-derived growth factor in megakaryocytes in guinea pigs.
    Chernoff A; Levine RF; Goodman DS
    J Clin Invest; 1980 Apr; 65(4):926-30. PubMed ID: 7358851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods for genetic modification of megakaryocytes and platelets.
    Pendaries C; Watson SP; Spalton JC
    Platelets; 2007 Sep; 18(6):393-408. PubMed ID: 17763148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic processes in megakaryocytes and platelets.
    White MJ; Kile BT
    Semin Hematol; 2010 Jul; 47(3):227-34. PubMed ID: 20620433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Platelets and Megakaryocytes by High-Resolution Laser Fluorescence Microscopy.
    Pluthero FG; Kahr WHA
    Methods Mol Biol; 2018; 1812():13-31. PubMed ID: 30171570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.
    Sim X; Poncz M; Gadue P; French DL
    Blood; 2016 Mar; 127(10):1227-33. PubMed ID: 26787738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small GTPases in megakaryocyte and platelet biology.
    Stefanini L; Bergmeier W
    Platelets; 2019; 30(1):7-8. PubMed ID: 30663476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization and manipulation of the platelet and megakaryocyte cytoskeleton.
    Thon JN; Italiano JE
    Methods Mol Biol; 2012; 788():109-25. PubMed ID: 22130704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional characteristics of megakaryocytes and platelets in aging.
    Esparza O; Higa K; Davizon-Castillo P
    Curr Opin Hematol; 2020 Sep; 27(5):302-310. PubMed ID: 32740036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors.
    Jarocha D; Vo KK; Lyde RB; Hayes V; Camire RM; Poncz M
    Blood Adv; 2018 Mar; 2(6):597-606. PubMed ID: 29545255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding megakaryocyte phenotypes and the impact on platelet biogenesis.
    Chen S; Looney MR
    Transfusion; 2024 Jul; 64(7):1372-1380. PubMed ID: 38923572
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of cytokines on in vivo megakaryocyte-platelet hematopoiesis and the analysis of their receptors].
    Ishibashi T; Shikima Y; Hamazaki Y; Kimura H
    Rinsho Ketsueki; 1992 May; 33(5):619-23. PubMed ID: 1321301
    [No Abstract]   [Full Text] [Related]  

  • 15. Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients.
    Di Buduo CA; Alberelli MA; Glembostky AC; Podda G; Lev PR; Cattaneo M; Landolfi R; Heller PG; Balduini A; De Candia E
    Sci Rep; 2016 Mar; 6():23213. PubMed ID: 26987485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets.
    Crist SA; Elzey BD; Ludwig AT; Griffith TS; Staack JB; Lentz SR; Ratliff TL
    Exp Hematol; 2004 Nov; 32(11):1073-81. PubMed ID: 15539085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in thromboxane A2 synthesis by megakaryocytes and platelets.
    Wojenski CM; Schick PK
    J Lab Clin Med; 1991 Oct; 118(4):370-6. PubMed ID: 1940580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A circle of life: platelet and megakaryocyte cytoskeleton dynamics in health and disease.
    Liu H; Welburn JPI
    Open Biol; 2024 Jun; 14(6):240041. PubMed ID: 38835242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coming of age of the megakaryocyte-platelet.
    Cooper N; Bussel JB; Cotter F
    Br J Haematol; 2014 Apr; 165(2):161-2. PubMed ID: 24690043
    [No Abstract]   [Full Text] [Related]  

  • 20. Proteoglycans in megakaryocyte development.
    Schick BP
    Prog Clin Biol Res; 1990; 356():93-104. PubMed ID: 2217453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.